<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font24 { font-size : 24; }</style>
 <body>
  <p>
   <span class="font32">drugs </span>
   <span class="font24">MT-DTI </span>
   <span class="font22">coronavirus </span>
   <span class="font22">prediction </span>
   <span class="font21">O)( </span>
   <span class="font21">O)C(NC( </span>
   <span class="font20">Table </span>
   <span class="font20">antiviral </span>
   <span class="font20">{border-style </span>
   <span class="font20">[]. </span>
   <span class="font19">O)NC(C( </span>
   <span class="font19">px;} </span>
   <span class="font18">#ffffff;} </span>
   <span class="font18">SARS-CoV- </span>
   <span class="font18">novel </span>
   <span class="font18">used </span>
   <span class="font17">drug-target </span>
   <span class="font17">nM), </span>
   <span class="font17">(Kd </span>
   <span class="font17">predicted </span>
   <span class="font17">proteinase </span>
   <span class="font17">results </span>
   <span class="font16">(accession </span>
   <span class="font16">C-like </span>
   <span class="font16">O)NS( </span>
   <span class="font16">SARS-CoV-. </span>
   <span class="font16">binding </span>
   <span class="font16">data </span>
   <span class="font16">interaction </span>
   <span class="font16">model </span>
   <span class="font16">COVID- </span>
   <span class="font16">FDA-approved </span>
   <span class="font16">RNA </span>
   <span class="font16">[], </span>
   <span class="font16">available </span>
   <span class="font16">viral </span>
   <span class="font15">DTI </span>
   <span class="font15">drug </span>
   <span class="font15">AutoDock </span>
   <span class="font15">COC( </span>
   <span class="font15">deep </span>
   <span class="font15">showed </span>
   <span class="font14">Ncnc( </span>
   <span class="font14">O)CCC </span>
   <span class="font14">Supplementary </span>
   <span class="font14">affinity </span>
   <span class="font14">study </span>
   <span class="font14">CCCC(NC( </span>
   <span class="font14">O)CCC)NC( </span>
   <span class="font14">RNA-dependent </span>
   <span class="font14">SMILES </span>
   <span class="font14">complex </span>
   <span class="font14">docking </span>
   <span class="font14">learning-based </span>
   <span class="font14">proteins </span>
   <span class="font14">px; </span>
   <span class="font14">replication </span>
   <span class="font14">respiratory </span>
   <span class="font14">sequence </span>
   <span class="font14">target </span>
   <span class="font14">treatment </span>
   <span class="font14">{font-family </span>
   <span class="font13">(DTI) </span>
   <span class="font13">Atazanavir </span>
   <span class="font13">CC(C)cnc(CN(C)C( </span>
   <span class="font13">LINK </span>
   <span class="font13">O)OCccncs)C(C)C)cs </span>
   <span class="font13">Vina </span>
   <span class="font13">affinities </span>
   <span class="font13">effective </span>
   <span class="font13">font-size </span>
   <span class="font13">helicase </span>
   <span class="font13">molecules </span>
   <span class="font13">polymerase </span>
   <span class="font13">predict </span>
   <span class="font13">syndrome </span>
   <span class="font13">′-O-ribose </span>
   <span class="font13">′-to-′ </span>
   <span class="font13">(SARS-CoV-, </span>
   <span class="font13">(Table </span>
   <span class="font13">CCC(CC)COC( </span>
   <span class="font13">CCCCOCCncc(C( </span>
   <span class="font13">CN)O)O)OC </span>
   <span class="font13">CNN </span>
   <span class="font13">CNcccc(Cl)cc[C@@](C#CCCC)(C(F)(F)F)O </span>
   <span class="font13">Dolutegravir </span>
   <span class="font13">Drug-target </span>
   <span class="font13">Efavirenz* </span>
   <span class="font13">However, </span>
   <span class="font13">NC_.) </span>
   <span class="font13">O)(OC[C@@H][C@H]([C@H]([C@](O)(C#N)C </span>
   <span class="font13">O)N </span>
   <span class="font13">O)NC(Ccccccc)C(O)CN(Ccccc(—cccccn)cc)NC( </span>
   <span class="font13">O)NCcccc(F)ccF)c( </span>
   <span class="font13">O)OC)C(C)(C)C)C(C)(C)C </span>
   <span class="font13">O)[C@H](C)N[P@]( </span>
   <span class="font13">O)c(O)cC( </span>
   <span class="font13">Rank </span>
   <span class="font13">Remdesivir* </span>
   <span class="font13">SMILES. </span>
   <span class="font13">Small </span>
   <span class="font13">YP_.). </span>
   <span class="font13">based </span>
   <span class="font13">bind </span>
   <span class="font13">clinical </span>
   <span class="font13">commercially </span>
   <span class="font13">double; </span>
   <span class="font13">form </span>
   <span class="font13">indicates </span>
   <span class="font13">inhibit </span>
   <span class="font13">isomeric </span>
   <span class="font13">markets </span>
   <span class="font13">potential </span>
   <span class="font13">previous </span>
   <span class="font13">reference </span>
   <span class="font13">using </span>
   <span class="font12">Asunaprevir </span>
   <span class="font12">CC(C)(C)NC( </span>
   <span class="font12">China </span>
   <span class="font12">O)CCC(Ocncc(OC)cccc(Cl)cc)CNC( </span>
   <span class="font12">O)NC(Ccccccc)CC(O)C(Ccccccc)NC( </span>
   <span class="font12">O)OC(C)(C)C)C(C)(C)C)C( </span>
   <span class="font12">Res </span>
   <span class="font12">Ritonavir </span>
   <span class="font12">YP_.), </span>
   <span class="font12">act </span>
   <span class="font12">acute </span>
   <span class="font12">atazanavir </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">database </span>
   <span class="font12">exonuclease </span>
   <span class="font12">identified </span>
   <span class="font12">inhibitory </span>
   <span class="font12">interactions </span>
   <span class="font12">methyltransferase </span>
   <span class="font12">model, </span>
   <span class="font12">potency </span>
   <span class="font12">proteinase, </span>
   <span class="font12">solid; </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font12">&amp;lt; </span>
   <span class="font12">Biotechnol </span>
   <span class="font12">C(\O)O[C@H]CO[C@H]OCC[C@@H])S( </span>
   <span class="font12">CC(C)(C)OC( </span>
   <span class="font12">CC(C)CN(C[C@@H](O)[C@H](Ccccccc)/N </span>
   <span class="font12">CCCCC(C( </span>
   <span class="font12">COccccc(O[C@H]CCC( </span>
   <span class="font12">C[C@H]C[C@](NC( </span>
   <span class="font12">C\[C@@H]C[C@@](CNS( </span>
   <span class="font12">C\[C@H]C[C@@](C( </span>
   <span class="font12">Cccccc(C)cOCC( </span>
   <span class="font12">Ccnnc(C( </span>
   <span class="font12">Daclatasvir </span>
   <span class="font12">Danoprevir* </span>
   <span class="font12">Darunavir* </span>
   <span class="font12">Grazoprevir* </span>
   <span class="font12">Lomibuvir </span>
   <span class="font12">Methodology, </span>
   <span class="font12">O)N(C)CCCC/C </span>
   <span class="font12">O)N(ccc(C#CC(C)(C)C)scC( </span>
   <span class="font12">O)NC(C)(C)cnc(C( </span>
   <span class="font12">O)NCCCCcncc(—cccc(—cccc(-ccnc(CCCCNC( </span>
   <span class="font12">O)NCcccc(F)cc)c(O)c( </span>
   <span class="font12">O)NCccccc(F)cC)CNC </span>
   <span class="font12">O)N[C@H]CCCCC/C </span>
   <span class="font12">O)O)CCCC(O)CC)CC </span>
   <span class="font12">O)OC)C(C)C)[nH])cc)cc)[nH])C(C)C </span>
   <span class="font12">O)O[C@@H]C[C@H]CCCCCcncccc(OC)ccncO)C( </span>
   <span class="font12">O)[C@@H]C)cc(—cnc(C(C)C)cs)nccC </span>
   <span class="font12">O)[C@@H]C[C@@H](OC( </span>
   <span class="font12">O)[C@@H]C[C@@H]CNC( </span>
   <span class="font12">O)[C@H](C(C)(C)C)NC( </span>
   <span class="font12">O)cccc(N)cc </span>
   <span class="font12">O)nC)o </span>
   <span class="font12">Raltegravir </span>
   <span class="font12">SARS-CoV-, </span>
   <span class="font12">Simeprevir* </span>
   <span class="font12">Target </span>
   <span class="font12">Writing </span>
   <span class="font12">acid </span>
   <span class="font12">and/or </span>
   <span class="font12">application </span>
   <span class="font12">approach </span>
   <span class="font12">best </span>
   <span class="font12">bold </span>
   <span class="font12">chemical </span>
   <span class="font12">chloroquine </span>
   <span class="font12">courier; </span>
   <span class="font12">darunavir </span>
   <span class="font12">em; </span>
   <span class="font12">endoRNAse </span>
   <span class="font12">following </span>
   <span class="font12">identify </span>
   <span class="font12">information </span>
   <span class="font12">potent </span>
   <span class="font12">pre-trained </span>
   <span class="font12">protein </span>
   <span class="font12">proteins, </span>
   <span class="font12">pt;} </span>
   <span class="font12">recent </span>
   <span class="font12">recently </span>
   <span class="font12">remdesivir </span>
   <span class="font12">ritonavir, </span>
   <span class="font12">sequences </span>
   <span class="font12">severe </span>
   <span class="font12">therapeutic </span>
  </p>
 </body>
</html>
